| Companies sponsors |
Bristol-Myers Squibb (Lisocabtagene maraleucel) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| Patient carer groups |
Blood Cancer UK |
| |
Lymphoma Action |
| Professional groups |
Association of Cancer Physicians |
| |
Cancer Research UK |
| |
Royal College of Physicians |
| |
Royal College of Radiologists |
| Associated public health groups |
None |
| Comparator companies |
Accord Healthcare (carboplatin, cisplatin, cytarabine, gemcitabine) (confidentiality agreement not signed, not participating) |
| |
Advanz Pharma (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Aspen (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Baxter Healthcare (ifosfamide) (confidentiality agreement not signed, not participating) |
| |
Cheplapharm Arzneimittel GmbH (etoposide) (confidentiality agreement not signed, not participating) |
| |
Glenmark Pharmaceuticals (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Hameln Pharma (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Hospira UK (carboplatin, cisplatin, cytarabine, dexamethasone, gemcitabine) (confidentiality agreement not signed, not participating) |
| |
Jazz Pharmaceuticals UK (cytarabine) (confidentiality agreement not signed, not participating) |
| |
Martindale Pharma (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Napp Pharmaceuticals (rituximab) (confidentiality agreement not signed, not participating) |
| |
Panpharma UK (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Pfizer (cytarabine, rituximab) (confidentiality agreement not signed, not participating) |
| |
Roche Products (rituximab) (confidentiality agreement not signed, not participating) |
| |
Rosemont Pharmaceuticals (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Sandoz (cisplatin, rituximab) (confidentiality agreement not signed, not participating) |
| |
Sun Pharmaceutical (gemcitabine) (confidentiality agreement not signed, not participating) |
| |
Synchrony Pharma (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Thame Laboratories (dexamethasone) (confidentiality agreement not signed, not participating) |
| |
Wockhardt UK (dexamethasone) (confidentiality agreement not signed, not participating) |
| General commentators |
All Wales Therapeutics & Toxicology Centre |
| |
British National Formulary |
| |
Department of Health, Social Services and Public Safety for Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
Institute of Cancer Research |